Epigenetic Mechanism of 5-HT/NE/DA Triple Reuptake Inhibitor on Adult Depression Susceptibility in Early Stress Mice
- PMID: 35370730
- PMCID: PMC8968447
- DOI: 10.3389/fphar.2022.848251
Epigenetic Mechanism of 5-HT/NE/DA Triple Reuptake Inhibitor on Adult Depression Susceptibility in Early Stress Mice
Abstract
Major depressive disorder (MDD) is a chronic, remitting and debilitating disease and the etiology of MDD is highly complicated that involves genetic and environmental interactions. Despite many pharmacotherapeutic options, many patients remain poorly treated and the development of effective treatments remains a high priority in the field. LPM570065 is a potent 5-hydroxytryptamine (5-HT), norepinephrine (NE) and dopamine (DA) triple reuptake inhibitor and both preclinical and clinical results demonstrate significant efficacy against MDD. This study extends previous findings to examine the effects and underlying mechanisms of LPM570065 on stress vulnerability using a "two-hit" stress mouse model. The "two-hit" stress model used adult mice that had experienced early life maternal separation (MS) stress for social defeat stress (SDS) and then they were evaluated in three behavioral assays: sucrose preference test, tail suspension test and forced swimming test. For the mechanistic studies, methylation-specific differentially expressed genes in mouse hippocampal tissue and ventral tegmental area (VTA) were analyzed by whole-genome transcriptome analysis along with next-generation bisulfite sequencing analysis, followed by RT-PCR and pyrophosphate sequencing to confirm gene expression and methylation. LPM570065 significantly reversed depressive-like behaviors in the mice in the sucrose preference test, the tail suspension test, and the forced swimming test. Morphologically, LPM570065 increased the density of dendritic spines in hippocampal CA1 neurons. Hypermethylation and downregulation of oxytocin receptor (Oxtr) in the hippocampal tissues along with increased protein expression of Dnmt1 and Dnmt3a in mice that experienced the "two-hit" stress compared to those that only experienced adulthood social defeat stress, and LPM570065 could reverse these changes. Combined, these results suggest that methylation specificity of the gene Oxtr in the hippocampus may play an important role in early life stress-induced susceptibility to depression and that the5-HT/NE/DA triple reuptake inhibitor LPM570065 may reduce depression susceptibility via the reversal of the methylation of the gene Oxtr.
Keywords: DNA methylation; depression susceptibility; epigenetics; second stress; triple reuptake inhibitors.
Copyright © 2022 Meng, Li, Duan, Ji, Xu, Mao, Wang and Tian.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures







Similar articles
-
The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamine and norepinephrine levels in rats.PLoS One. 2014 Mar 10;9(3):e91775. doi: 10.1371/journal.pone.0091775. eCollection 2014. PLoS One. 2014. PMID: 24614602 Free PMC article.
-
Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors.Curr Drug Targets. 2009 Nov;10(11):1069-84. doi: 10.2174/138945009789735156. Curr Drug Targets. 2009. PMID: 19702555 Review.
-
Characterization of the electrophysiological properties of triple reuptake inhibitors on monoaminergic neurons.Int J Neuropsychopharmacol. 2011 Mar;14(2):211-23. doi: 10.1017/S1461145710000076. Epub 2010 Feb 11. Int J Neuropsychopharmacol. 2011. PMID: 20149268
-
Triple reuptake inhibition of serotonin, norepinephrine, and dopamine increases the tonic activation of α2-adrenoceptors in the rat hippocampus and dopamine levels in the nucleus accumbens.Prog Neuropsychopharmacol Biol Psychiatry. 2020 Dec 20;103:109987. doi: 10.1016/j.pnpbp.2020.109987. Epub 2020 May 29. Prog Neuropsychopharmacol Biol Psychiatry. 2020. PMID: 32474007
-
Monoamine neurocircuitry in depression and strategies for new treatments.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:54-63. doi: 10.1016/j.pnpbp.2013.04.009. Epub 2013 Apr 19. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23602950 Review.
Cited by
-
Exploring the Potential of Coumarin Derivatives on Serotonin Receptors 5-HT1A and 5HT2A.Int J Mol Sci. 2025 Feb 24;26(5):1946. doi: 10.3390/ijms26051946. Int J Mol Sci. 2025. PMID: 40076572 Free PMC article.
-
Epigenetic Modifications and Neuroplasticity in the Pathogenesis of Depression: A Focus on Early Life Stress.Behav Sci (Basel). 2024 Oct 1;14(10):882. doi: 10.3390/bs14100882. Behav Sci (Basel). 2024. PMID: 39457754 Free PMC article. Review.
-
Efficacy, Tolerability, and Safety of Toludesvenlafaxine for the Treatment of Major Depressive Disorder-A Narrative Review.Pharmaceuticals (Basel). 2023 Mar 8;16(3):411. doi: 10.3390/ph16030411. Pharmaceuticals (Basel). 2023. PMID: 36986510 Free PMC article. Review.
-
Does urinary metabolite signature act as a biomarker of post-stroke depression?Front Psychiatry. 2022 Aug 24;13:928076. doi: 10.3389/fpsyt.2022.928076. eCollection 2022. Front Psychiatry. 2022. PMID: 36090365 Free PMC article. Review.
-
Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H3 Agents: Synthesis and Biological Evaluation.Molecules. 2024 Nov 6;29(22):5240. doi: 10.3390/molecules29225240. Molecules. 2024. PMID: 39598630 Free PMC article.
References
-
- Ämmälä A. J., Urrila A. S., Lahtinen A., Santangeli O., Hakkarainen A., Kantojärvi K., et al. (2019). Epigenetic Dysregulation of Genes Related to Synaptic Long-Term Depression Among Adolescents with Depressive Disorder and Sleep Symptoms. Sleep Med. 61, 95–103. 10.1016/j.sleep.2019.01.050 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous